Company intelligence / Profile preview
Hainan Poly Pharm
Haikou, Hainan, Chinahnpoly.com ↗
- Ownership
- Private
- Employees
- ~1565
- Development stage
- Other
01
Overview
Hainan Poly Pharm is a leading pharmaceutical and CDMO company specializing in APIs, generics, and serving as a contract manufacturer for innovative modalities like DNA and mRNA vaccines. It has a strong portfolio covering both Chinese and international regulatory approvals, with ongoing manufacturing partnerships for innovative therapies and a robust presence in generic and complex formulation markets[1][4][9].
- Therapeutic areas
- Infectious DiseasesNeurologyOtherOncology
- Modalities
- Small moleculemRNA-based drugsTherapeutic vaccineContrast agent
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Celsion (GEN-1 ovarian cancer immunotherapy, DNA vaccine CDMO services)
Beyond the preview
Go deeper on Hainan Poly Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hainan Poly Pharm.